Share this page

 BORSANTRAZOLE — 2392713

Toolbar

Toolbar

Details

Third-party disclaimer

Share this page

No endorsement of any products or services is expressed or implied.

Third-party disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Application number

2392713

Type(s)

Standard Characters

Category

Trademark

CIPO Status

ADVERTISED

TM5 status

LIVE/APPLICATION/ Published for Opposition
A pending trademark application has been examined by the Office and has been published in a way that provides an opportunity for the public to oppose its registration.

Filed

2025-04-16

Applicant

Borotherapeutics Ltd.
4 Sunridge Place
East St Paul
MANITOBA R2E0G4

Agent

MLT AIKINS LLP
2100 Livingston Place
222-3rd Avenue SW
Calgary
ALBERTA T2P0B4

Documents

View documents

Index headings

  • BORSANTRAZOLE
  • BORSAN TRAZOLE

Goods (Nice class & Statement)

5
(1) Pharmaceutical preparations and medicine for the treatment of neurodegenerative diseases, namely, amyotrophic lateral sclerosis (ALS).

Action History

Actions
Action Action date Due date Comments
Filed 2025-04-16
Created 2025-04-16
Formalized 2025-04-16
Pre-Assessment Letter Sent 2025-05-01 Acceptable Goods or Services
Search Recorded 2026-02-05
Approved 2026-02-13 APPROVED BY PROGRAM EX200M1
Approval Notice Sent 2026-02-13 APPROVED BY PROGRAM EX200M1
Advertised 2026-05-06 Vol.73 Issue 3732
Report a problem on this page
Date modified: